APOE and atherosclerosis: A recent study conducted in non-diabetic ApoE − / − mice highlighted that EMPA inhibited the progression of atherosclerosis by lipid lowering, reducing the inflammatory profile and downregulation of sympathetic activity as evidenced by decreases in markers of the SNS such as norepinephrine and neuropeptide Y [26••].